SFERA Archivio dei prodotti della Ricerca dell'Università di Ferrara

TRENTINI, Alessandro
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 6.305
EU - Europa 2.142
AS - Asia 1.548
OC - Oceania 13
AF - Africa 9
Continente sconosciuto - Info sul continente non disponibili 7
SA - Sud America 6
Totale 10.030
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 6.275
IT - Italia 675
CN - Cina 658
PL - Polonia 435
SG - Singapore 424
UA - Ucraina 243
DE - Germania 242
TR - Turchia 209
GB - Regno Unito 161
ID - Indonesia 96
SE - Svezia 85
FI - Finlandia 80
HK - Hong Kong 57
IE - Irlanda 42
BE - Belgio 38
CZ - Repubblica Ceca 29
CA - Canada 28
FR - Francia 27
VN - Vietnam 27
ES - Italia 16
KR - Corea 16
NL - Olanda 15
IR - Iran 13
IN - India 11
TW - Taiwan 11
AT - Austria 10
AU - Australia 10
RO - Romania 9
BG - Bulgaria 7
MY - Malesia 7
SD - Sudan 7
IQ - Iraq 6
JP - Giappone 6
LT - Lituania 5
PT - Portogallo 5
EU - Europa 4
SK - Slovacchia (Repubblica Slovacca) 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BR - Brasile 3
HR - Croazia 3
NZ - Nuova Zelanda 3
SI - Slovenia 3
AL - Albania 2
DK - Danimarca 2
EG - Egitto 2
PH - Filippine 2
AE - Emirati Arabi Uniti 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CH - Svizzera 1
CO - Colombia 1
GE - Georgia 1
HU - Ungheria 1
LV - Lettonia 1
MD - Moldavia 1
MX - Messico 1
PA - Panama 1
PE - Perù 1
PK - Pakistan 1
TH - Thailandia 1
Totale 10.030
Salva come PNG Salva come JPEG
Città #
Fairfield 776
Woodbridge 701
Ann Arbor 492
Chandler 452
Ashburn 428
Warsaw 419
Houston 412
Singapore 340
Jacksonville 316
Ferrara 295
Seattle 277
Santa Clara 276
Wilmington 260
Cambridge 251
Izmir 156
Beijing 127
Nanjing 121
Princeton 115
Menlo Park 98
Jakarta 91
Shanghai 81
Boardman 75
Milan 71
Dearborn 55
Hong Kong 52
San Diego 52
Addison 48
Bologna 45
Nanchang 40
Bremen 37
Brussels 37
Los Angeles 37
Shenyang 37
New York 32
Munich 30
Dong Ket 27
Falls Church 26
Brno 24
Changsha 24
Tianjin 24
Jiaxing 21
London 19
Hebei 18
Redwood City 18
Helsinki 17
Norwalk 16
Ningbo 15
Orange 15
Washington 14
Toronto 13
Jinan 12
Mountain View 12
St Louis 12
Guangzhou 11
Auburn Hills 10
Augusta 10
Rome 10
Hefei 9
Kraków 9
Vienna 9
Casalecchio Di Reno 8
Des Moines 8
Leawood 8
Montréal 8
San Mateo 8
Chicago 7
Indiana 7
Taizhou 7
Zhengzhou 7
Ferrara di Monte Baldo 6
Kunming 6
Taipei 6
Tappahannock 6
Cagliari 5
Frankfurt am Main 5
Kilburn 5
Lübeck 5
Modena 5
Wageningen 5
Clifton 4
Dublin 4
Falkenstein 4
Haikou 4
Khartoum 4
Lanzhou 4
Melbourne 4
Monmouth Junction 4
Ottawa 4
Padova 4
Parma 4
Philadelphia 4
Shah Alam 4
Tokyo 4
Wuhan 4
Amsterdam 3
Berlin 3
Calderara Di Reno 3
Hangzhou 3
Lappeenranta 3
Las Vegas 3
Totale 7.727
Salva come PNG Salva come JPEG
Nome #
Serum beta-secretase 1 (BACE1) activity as candidate biomarker for late-onset Alzheimer’s disease 227
Serum paraoxonase and arylesterase activities of paraoxonase-1 (PON-1), mild cognitive impairment, and 2-year conversion to dementia: A pilot study 193
Gelatinases, Neurofilaments and N-Acetyl aspartic Acid as Biomarkers in Different Pathologies 181
Decreased Arylesterase activity of Paraoxonase-1 (PON-1) might be a common denominator of neuroinflammatory and neurodegenerative diseases 174
Influence of Vaginal Lactoferrin Administration on Amniotic Fluid Cytokines and its Role Against Inflammatory Complications of Pregnancy 167
null 163
“Bridging the Gap” Everything that Could Have Been Avoided If We Had Applied Gender Medicine, Pharmacogenetics and Personalized Medicine in the Gender-Omics and Sex-Omics Era 163
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study. 156
TIMP-1 resistant matrix metalloproteinase-9 is the predominant serum active isoform associated with MRI activity in patients with multiple sclerosis 156
Low-grade systemic inflammation is associated with functional disability in elderly people affected by dementia 149
Evaluation of total, ceruloplasmin-associated and type II ferroxidase activities in serum and cerebrospinal fluid of multiple sclerosis patients 148
Paraoxonase-1 activities in individuals with different HDL circulating levels: Implication in reverse cholesterol transport and early vascular damage 142
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 140
Extrapulmonary tuberculosis among immigrants in a low-TB burden and high immigrant receiving city of northern Italy 140
Changes in adipose tissue distribution and association between uric acid and bone health during menopause transition 139
Subclinical Leishmania infection in patients with rheumatic diseases under biological drugs 132
Vaginal lactoferrin modulates PGE2, MMP-9, MMP-2, and TIMP-1 amniotic fluid concentrations 130
Paraoxonase, arylesterase and lactonase activities of paraoxonase-1 (PON1) in obese and severely obese women 129
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 129
null 128
Study of the potential influence of obesity on the activities of serum Paraoxonase-1 and lipoprotein-associated phospholipase A2 128
Leishmania Infantum Cryptic Infection in Immunosuppressed Rheumatologic Patients and Healthy Controls from Northern Italy: Epidemiological Variables That Can Affect Infection Risk 127
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 127
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 123
TRAIL and Ceruloplasmin Inverse Correlation as a Representative Crosstalk between Inflammation and Oxidative Stress 123
Monocyte count at onset predicts poststroke outcomes during a 90-day follow-up 121
Mutual relationship between serum ferroxidase activity and hemoglobin levels in elderly individuals 121
Leptin/adiponectin ratio predicts post-stroke neurological outcome 118
Serum Gelatinases Levels in Multiple Sclerosis Patients during 21 Months of Natalizumab Therapy 117
Sex difference: an important issue to consider in epidemiological and clinical studies dealing with serum paraoxonase-1 113
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 113
null 110
Proteomic analysis of 4-hydroxynonenal and nitrotyrosine modified proteins in RTT fibroblasts 110
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 109
Serum from patients affected by Alzheimer disease shows a paraoxonase-dependent pro-apoptotic effect on endothelial cells 108
Antiglaucoma drops influence the production of advanced glycation end-products (AGEs) in the conjunctival sac fluid of glaucoma patients 107
null 106
Matrix metalloproteinase-2 (MMP-2) generates soluble HLA-G1 by cell surface proteolytic shedding 105
Epidemiologia ed Outcome delle Infezioni della Cute e dei Tessuti Molli Osservate a Ferrara nel Quinquennio 2011-2016 105
null 97
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 97
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 97
Balanced and unbalanced solutions modulate the release of Matrix Metalloproteinase-9 (MMP-9) from neutrophils in response to inflammatory stimuli: an in vitro study 97
Evaluation of a possible role of oxidative stress in climacteric symptoms. 97
A proteomic approach to detect gelatinases levels and their inhibitors in patients with neurological diseases 97
Antiproliferative effects of novel synthetic nucleobase analogues on U937 Histiocytic lymphoma cell line 93
Effect of pH on MMP-9 release by LPS-stimulated neutrophils 91
Multiplex Matrix Metalloproteinases Analysis in the Cerebrospinal Fluid Reveals Potential Specific Patterns in Multiple Sclerosis Patients 90
Fast skeletal troponin i, but not the slow isoform, is increased in patients under statin therapy: A pilot study 89
Schematic overview of oligosaccharides, with survey on their major physiological effects and a focus on milk ones 89
Hydroxyethyl Starch 130/0.4 Binds to Neutrophils Impairing Their Chemotaxis through a Mac-1 Dependent Interaction 88
Testing a Combination of Markers of Systemic Redox Status as a Possible Tool for the Diagnosis of Late Onset Alzheimer's Disease 87
Decrease Paraoxonase-1 (PON-1) Activities in Neurodegenerative Diseases 87
Low Molecular Weight Heparin as inhibitor of gelatinases: possile anti-inflammatory role 86
null 86
Finding peculiar patterns of kinetoplastida enzymes to be exploited in drug design 85
null 85
Sex difference impacts on the relationship between paraoxonase-1 (Pon1) and type 2 diabetes 85
SERUM GELATINASES LEVELS IN MULTIPLE SCLEROSIS PATIENTS DURING 21 MONTHS OF NATALIZUMAB TREATMENT 84
null 83
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 83
Effect of antiglaucoma drops on advanced glycation end-products (AGEs) levels in conjunctival sac fluid 82
Implication of oxidative stress in dementia: data from cross-sectional and longitudinal study 80
Increased blood BACE1 activity as a potential common pathogenic factor of vascular dementia and late onset Alzheimer's disease 79
null 78
Purification of transglutaminase enzyme from Leishmania infantum promastigotes 74
Fluids administration modulate the matrix metalloproteinase-9 (MMP-9), myeloperoxidase (MPO) activities and inflammatory neutrophils response 68
EVALUATION OF THE SWITCH TO A DUAL ART REGIMEN WITH LAMIVUDINE PLUS DOLUTEGRAVIR OR PROTEASE INHIBITORS IN HIV-INFECTED VIROLOGICALLY SUPPRESSED PATIENTS. A REAL LIFE EXPERIENCE 68
null 68
Arylesterase activity of paraoxonase-1 in serum and cerebrospinal fluid of patients with alzheimer’s disease and vascular dementia 66
A Comparison Between Different Anti-Retroviral Therapy Regimes on Soluble Inflammation Markers: a Pilot Study 66
Gelatinase: enzymatic activity as potential biomarker in multiple sclerosis 66
Matrix metalloproteinase-2 (MMP-2) immune functions via surface proteolytic shedding of HLA-G1 molecules 65
Inflammation and axonal damage biomarkers in Multiple Sclerosis: new perspective on their role 65
Decreased serum PCSK9 levels after ischemic stroke predict worse outcomes 65
Gelatinases: enzymatic activity as potential biomarker in multiple sclerosis 65
Purification of transglutaminase enzyme from L. infantum promastigotes 62
Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology: A Systematic Review and Meta-analysis 61
Heparin binds Matrix Metalloproteinase-9 (MMP-9): effect on the proteolytic activity 60
Gelatinase A (MMP-2) and B (MMP-9): their active forms as biomarkers in multiple sclerosis 59
Serum Ferroxidase Activity in Patients with Multiple Sclerosis: A Pilot Study 59
Fluids administration can modulate inflammatory neutrophils response and MMP-9 activity: an in vitro study 58
Diaphragmatic dysfunction in critically patients undergoing mechanical ventilation 58
Development, optimization and validation of an absolute specific assay for active myeloperoxidase (MPO) and its application in a clinical context: Role of MPO specific activity in coronary artery disease 58
Clinical and Laboratory Findings in Tick-Borne Encephalitis Virus Infection 57
Matrix Metalloprotease-9 activity detected in body fluids is the result of two different enzyme forms 57
Extracellular pH modulates the release of Matrix Metalloproteinase-9 (MMP-9) by stimulated neutrophils and its activity. 53
null 49
MMP-9 isoforms in serum of Multiple Sclerosis patients 49
Association between Serum Concentrations of Apolipoprotein A-I (ApoA-I) and Alzheimer’s Disease: Systematic Review and Meta-Analysis 49
The influence of different replacement solutions on neutrophils response 47
The sex-specific detrimental effect of diabetes and gender-related factors on pre-admission medication adherence among patients hospitalized for ischemic heart disease: Insights from EVA study 46
null 44
Inflammation in Neurological Disorders: The Thin Boundary between Brain and Periphery 43
Circulating Skeletal Troponin During Weaning From Mechanical Ventilation and Their Association to Diaphragmatic Function: A Pilot Study 39
Connection between the Altered HDL Antioxidant and Anti-Inflammatory Properties and the Risk to Develop Alzheimer's Disease: A Narrative Review 38
Fermentation of Vaccinium floribundum Berries with Lactiplantibacillus plantarum Reduces Oxidative Stress in Endothelial Cells and Modulates Macrophages Function 38
Tuberculosis Epidemiology and Drug Resistance Among Immigrants and Natives in a City of Northern Italy 37
Brain and serum cholesterol dyshomeostasis during the perimenopausal transition: A possible risk factor for Alzheimer’s disease 37
Serum Apo J as a potential marker of conversion from mild cognitive impairment to dementia 37
Totale 9.500
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.945
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.945
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.229 0 0 0 0 115 207 211 190 189 171 86 60
2020/20211.782 106 110 94 154 162 164 102 185 89 310 181 125
2021/20221.247 100 145 155 42 41 75 61 71 37 113 58 349
2022/20231.137 119 104 35 135 174 146 72 111 125 9 65 42
2023/2024864 67 84 37 24 94 98 42 78 44 33 43 220
2024/20251.063 106 98 292 148 419 0 0 0 0 0 0 0
Totale 10.397